February 22, 2017
David Seftel, CSO and Peter Robinson, CEO
Enable Biosciences is a recent addition to the QB3@953 family – a spinout from the PhD work of a pair of Berkeley / Stanford grad students. Come hear the story of how two scientists with no business background teamed up with a sports medicine physician from South Africa to build the next generation of diabetes-screening technologies.
Peter Robinson, PhD, is the CSO of Enable Biosciences. After completing his graduate work in chemistry at UC Berkeley and Stanford in 2016, he joined Enable Biosciences full-time. With Enable Biosciences, he won several startup competitions, including the Harvard Business School New Ventures Competition, the Diabetes Innovation Challenge, and the Stanford Predictives and Diagnostics Accelerator prize.